InsidersTradesSigma
Follow the LIFECORE BIOMEDICAL INC stock price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €165.8m. The latest transaction was filed on 29 November 2022 (Acquisition). Among the most active insiders: WYNNEFIELD PARTNERS SMALL CAP VALUE LP I. The full history is openly available.
Analysts rate LIFECORE BIOMEDICAL INC Buy (bullish), based on 3 analysts. Average price target: US$6.83.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
LIFECORE BIOMEDICAL INC is a company focused on the development and manufacturing of biomedical products. It is listed on the NASDAQ.